Track the AstraZeneca PLC share price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, AstraZeneca PLC has recorded 1 reports. Market capitalisation: €195.3bn. The latest transaction was reported on 7 August 2026 (Attribution). Among the most active insiders: Sharma Mani. All data is free.
Analysts rate AstraZeneca PLC Buy (bullish), based on 22 analysts. Average price target: £15,772.18.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
AstraZeneca PLC es una compañía farmacéutica global enfocada en la investigación, desarrollo y comercialización de medicamentos en los campos de la oncología, enfermedades cardiovasculares y respiratorias. Cotiza en la Bolsa de Estocolmo bajo el símbolo XSTO.
AstraZeneca trades with healthcare inflows and a fresh trial setback, while the only recent insider move was a small Aug...
AstraZeneca fell on merger reports with Bristol Myers Squibb, after strong first-half results and no fresh insider trade...